Internal product development is often viewed as
a. carrying a high risk of failure.
b. the only reliable method of generating new products for the firm.
c. a quicker method of product launch than acquisition of another firm.
d. critical to the success of biotech and pharmaceutical firms.
Answer: carrying a high risk of failure.